Harbor Investment Advisory’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,942
| Closed | -$36.3K | – | 1207 |
|
|
2024
Q4 | $36.3K | Hold |
2,942
| – | – | ﹤0.01% | 650 |
|
|
2024
Q3 | $33.5K | Hold |
2,942
| – | – | ﹤0.01% | 660 |
|
|
2024
Q2 | $21K | Hold |
2,942
| – | – | ﹤0.01% | 735 |
|
|
2024
Q1 | $19.7K | Hold |
2,942
| – | – | ﹤0.01% | 740 |
|
|
2023
Q4 | $19.1K | Hold |
2,942
| – | – | ﹤0.01% | 725 |
|
|
2023
Q3 | $27.8K | Hold |
2,942
| – | – | ﹤0.01% | 639 |
|
|
2023
Q2 | $41.1K | Hold |
2,942
| – | – | 0.01% | 759 |
|
|
2023
Q1 | $55.2K | Hold |
2,942
| – | – | 0.01% | 678 |
|
|
2022
Q4 | $40.5K | Hold |
2,942
| – | – | 0.01% | 742 |
|
|
2022
Q3 | $56K | Hold |
2,942
| – | – | 0.01% | 658 |
|
|
2022
Q2 | $45K | Hold |
2,942
| – | – | 0.01% | 733 |
|
|
2022
Q1 | $60K | Hold |
2,942
| – | – | 0.01% | 695 |
|
|
2021
Q4 | $86K | Hold |
2,942
| – | – | 0.01% | 580 |
|
|
2021
Q3 | $63K | Hold |
2,942
| – | – | 0.01% | 670 |
|
|
2021
Q2 | $75K | Hold |
2,942
| – | – | 0.01% | 584 |
|
|
2021
Q1 | $54K | Hold |
2,942
| – | – | 0.01% | 664 |
|
|
2020
Q4 | $34K | Buy |
2,942
+115
| +4% | +$1.05K | 0.01% | 729 |
|
|
2020
Q3 | $22K | Hold |
2,827
| – | – | ﹤0.01% | 719 |
|
|
2020
Q2 | $19K | Hold |
2,827
| – | – | ﹤0.01% | 653 |
|
|
2020
Q1 | $14K | Hold |
2,827
| – | – | ﹤0.01% | 668 |
|
|
2019
Q4 | $22K | Buy |
+2,827
| New | +$16.5K | 0.01% | 533 |
|
Other funds holding CDMO
Harbor Investment Advisory's CDMO Position: Q1 2025 in Review
Harbor Investment Advisory sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 2,942 shares — an estimated $36.3K sold.
Harbor Investment Advisory first reported a position in CDMO in Q4 2019 and held it in 21 quarters. The position peaked at $86K in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Harbor Investment Advisory reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Harbor Investment Advisory sold 2,942 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $36.3K.
- Harbor Investment Advisory first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 21 quarters.
- Harbor Investment Advisory's Avid Bioservices, Inc. Common Stock position peaked at $86K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Harbor Investment Advisory's 13F filing for Q1 2025, filed 9 Apr 2025.